Literature DB >> 25556944

Probes to monitor activity of the paracaspase MALT1.

Janna Hachmann1, Laura E Edgington-Mitchell2, Marcin Poreba3, Laura E Sanman4, Marcin Drag3, Matthew Bogyo5, Guy S Salvesen6.   

Abstract

The human paracaspase mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) plays a central role in nuclear factor-κB (NF-κB) signaling as both a protease and scaffolding protein. Knocking out MALT1 leads to impaired NF-κB signaling and failure to mount an effective immune response. However, it is unclear to which degree it is the scaffolding function versus the proteolytic activity of MALT1 that is essential. Previous work involving a MALT1 inhibitor with low selectivity suggests that the enzymatic function plays an important role in different cell lines. To help elucidate this proteolytic role of MALT1, we have designed activity-based probes that inhibit its proteolytic activity. The probes selectively label active enzyme and can be used to inhibit MALT1 and trace its activity profile, helping to create a better picture of the significance of the proteolytic function of MALT1.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25556944      PMCID: PMC4304901          DOI: 10.1016/j.chembiol.2014.11.011

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  49 in total

1.  Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation.

Authors:  Shaun Rosebeck; Lisa Madden; Xiaohong Jin; Shufang Gu; Ingrid J Apel; Alex Appert; Rifat A Hamoudi; Heidi Noels; Xavier Sagaert; Peter Van Loo; Mathijs Baens; Ming-Qing Du; Peter C Lucas; Linda M McAllister-Lucas
Journal:  Science       Date:  2011-01-28       Impact factor: 47.728

Review 2.  MALT lymphoma: from morphology to molecules.

Authors:  Peter G Isaacson; Ming-Qing Du
Journal:  Nat Rev Cancer       Date:  2004-08       Impact factor: 60.716

3.  Mechanism and specificity of the human paracaspase MALT1.

Authors:  Janna Hachmann; Scott J Snipas; Bram J van Raam; Erik M Cancino; Emily J Houlihan; Marcin Poreba; Paulina Kasperkiewicz; Marcin Drag; Guy S Salvesen
Journal:  Biochem J       Date:  2012-04-01       Impact factor: 3.857

4.  Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines.

Authors:  Stephan Hailfinger; Hendrik Nogai; Christiane Pelzer; Maike Jaworski; Katrin Cabalzar; Jean-Enno Charton; Montserrat Guzzardi; Chantal Décaillet; Michael Grau; Bernd Dörken; Peter Lenz; Georg Lenz; Margot Thome
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

5.  Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18.

Authors:  J A Morgan; Y Yin; A D Borowsky; F Kuo; N Nourmand; J I Koontz; C Reynolds; L Soreng; C A Griffin; F Graeme-Cook; N L Harris; D Weisenburger; G S Pinkus; J A Fletcher; J Sklar
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

6.  T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1.

Authors:  Jens Staal; Yasmine Driege; Tine Bekaert; Annelies Demeyer; David Muyllaert; Petra Van Damme; Kris Gevaert; Rudi Beyaert
Journal:  EMBO J       Date:  2011-03-29       Impact factor: 11.598

7.  Crystal structure of the mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) paracaspase region.

Authors:  Jong W Yu; Philip D Jeffrey; Jun Yong Ha; Xiaolu Yang; Yigong Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-07       Impact factor: 11.205

8.  Oncogenic CARD11 mutations induce hyperactive signaling by disrupting autoinhibition by the PKC-responsive inhibitory domain.

Authors:  Rebecca L Lamason; Ryan R McCully; Stefanie M Lew; Joel L Pomerantz
Journal:  Biochemistry       Date:  2010-09-28       Impact factor: 3.162

9.  Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma.

Authors:  Stephan Hailfinger; Georg Lenz; Vu Ngo; Anita Posvitz-Fejfar; Fabien Rebeaud; Montserrat Guzzardi; Eva-Maria Murga Penas; Judith Dierlamm; Wing C Chan; Louis M Staudt; Margot Thome
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-06       Impact factor: 11.205

10.  Oligomeric structure of the MALT1 tandem Ig-like domains.

Authors:  Liyan Qiu; Sirano Dhe-Paganon
Journal:  PLoS One       Date:  2011-09-23       Impact factor: 3.240

View more
  9 in total

1.  Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth.

Authors:  Lorena Fontán; Qi Qiao; John M Hatcher; Gabriella Casalena; Ilkay Us; Matt Teater; Matt Durant; Guangyan Du; Min Xia; Natalia Bilchuk; Spandan Chennamadhavuni; Giuseppe Palladino; Giorgio Inghirami; Ulrike Philippar; Hao Wu; David A Scott; Nathanael S Gray; Ari Melnick
Journal:  J Clin Invest       Date:  2018-07-19       Impact factor: 14.808

2.  Differing Requirements for MALT1 Function in Peripheral B Cell Survival and Differentiation.

Authors:  Peishan Lee; Zilu Zhu; Janna Hachmann; Takuya Nojima; Daisuke Kitamura; Guy Salvesen; Robert C Rickert
Journal:  J Immunol       Date:  2016-12-28       Impact factor: 5.422

Review 3.  The Paracaspase MALT1.

Authors:  Janna Hachmann; Guy S Salvesen
Journal:  Biochimie       Date:  2015-09-16       Impact factor: 4.079

Review 4.  Protease signaling in animal and plant-regulated cell death.

Authors:  Guy S Salvesen; Anne Hempel; Nuria S Coll
Journal:  FEBS J       Date:  2015-12-31       Impact factor: 5.542

Review 5.  Post-translational Modifications of the CARMA1-BCL10-MALT1 Complex in Lymphocytes and Activated B-Cell Like Subtype of Diffuse Large B-Cell Lymphoma.

Authors:  An Thys; Tiphaine Douanne; Nicolas Bidère
Journal:  Front Oncol       Date:  2018-11-09       Impact factor: 6.244

Review 6.  Emerging challenges in the design of selective substrates, inhibitors and activity-based probes for indistinguishable proteases.

Authors:  Paulina Kasperkiewicz; Marcin Poreba; Katarzyna Groborz; Marcin Drag
Journal:  FEBS J       Date:  2017-01-29       Impact factor: 5.542

Review 7.  Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.

Authors:  Mélanie Juilland; Margot Thome
Journal:  Curr Opin Hematol       Date:  2016-07       Impact factor: 3.284

Review 8.  The paracaspase MALT1: biological function and potential for therapeutic inhibition.

Authors:  Maike Jaworski; Margot Thome
Journal:  Cell Mol Life Sci       Date:  2015-10-27       Impact factor: 9.261

9.  Determination of extended substrate specificity of the MALT1 as a strategy for the design of potent substrates and activity-based probes.

Authors:  Paulina Kasperkiewicz; Sonia Kołt; Tomasz Janiszewski; Katarzyna Groborz; Marcin Poręba; Scott J Snipas; Guy S Salvesen; Marcin Drąg
Journal:  Sci Rep       Date:  2018-10-30       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.